← All companies

TDAC

Translational Development Acquisition Corp.

TDAC Nasdaq Blank Checks EDGAR ↗

$10.83

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

$6.21M

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$24.6K

Total assets

$183M

Gross margin

—

52-week range

$10.32 – $10.90

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Unregistered sale of equity Jul 27, 2026 8-K Other events Jul 8, 2026 8-K Other events Jun 23, 2026 8-K Entered a material agreement; Amended charter or bylaws; Shareholder vote results Jun 18, 2026 8-K Unregistered sale of equity Jun 12, 2026 8-K Entered a material agreement; Regulation FD disclosure May 27, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 May 11, 2026 10-K/A Fiscal year ended 2025-12-31 May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Took on a direct financial obligation; Other events Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Other events Feb 14, 2025 8-K Other events Dec 31, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Other events Dec 27, 2024

Other filings

425 Aug 3, 2026 425 Jul 28, 2026 425 Jul 27, 2026 SCHEDULE 13G/A Jul 16, 2026 425 Jun 29, 2026 DEFA14A Jun 23, 2026 425 Jun 23, 2026 425 Jun 23, 2026 425 Jun 22, 2026 425 Jun 15, 2026 425 Jun 10, 2026 425 Jun 2, 2026 SCHEDULE 13G Jun 2, 2026 4 OWNERSHIP DOCUMENT May 29, 2026 DEFA14A May 28, 2026 DEF 14A May 27, 2026 425 May 27, 2026 SCHEDULE 13G May 13, 2026 PRE 14A May 1, 2026 SCHEDULE 13G/A Oct 10, 2025 SCHEDULE 13G/A Jul 31, 2025 SCHEDULE 13G/A Jul 11, 2025